OR7E149P

Across TCGA pan-cancer cohorts, OR7E149P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR7E149P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR7E149P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E149P expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

MESO, UCEC, and HNSC are the cancer types where OR7E149P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	126	view →
UCEC	DFS	Tertile	II,III,IV	0.613	0.836	<.001	108	view →
HNSC	OS	Tertile	II,III,IV	0.196	0.710	.023	33	view →
KIRC	DFS	Tertile	All	0.173	0.634	.001	30	view →
THCA	DFS	Tertile	II,III,IV	0.180	0.793	.008	27	view →
ESCA	OS	Tertile	All	0.289	0.544	.024	27	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	27	view →
LGG	DFS	Tertile	All	0.365	0.742	.001	24	view →
SARC	OS	Tertile	All	0.126	0.860	<.001	18	view →
PRAD	DFS	Tertile	All	0.680	0.890	.008	18	view →
KIRP	DFS	Tertile	IV	0.088	0.511	.002	18	view →
LUAD	OS	Tertile	II,III,IV	0.727	0.382	.015	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR7E149P–MESO (OS)

Open the MESO breakdown →